Gunilla Ajne

Gunilla Ajne

Affiliated to Research | Docent
Visiting address: Hälsovägen, Enheten för obstetrik och gynekologi K65, 14186 Stockholm
Postal address: H9 Klinisk vetenskap, intervention och teknik, H9 CLINTEC Obstetrik o gynekologi, 141 52 Huddinge

About me

  • Senior consultant and Medical manager at the Delivery Department Huddinge,
    Pregnancy Care & Delivery, Karolinska University Hospital.
    Medical manager in Stockholm County regarding erythrocyte- and thrombocyte
    immunization during pregnancy.
    Associated researcher, Dept. of Obstetrics and Gynaecology, Clintec, KI
    Organiser of annual courses in complicated pregnancies. Teaching interest in
    high-risk pregnancies, obstetric delivery and erythrocyte- and thrombocyte
    immunization in pregnancy. Author of Swedish textbooks chapters in
    obstetrics.

Research

  • Main research field is within clinical obstetrics. Responsible for a research
    group investigating fetal and maternal effects after vacuum assisted
    instrumental delivery, including development of medical technical
    devices.
    Has an interest in liver diseases during pregnancy. Collaborates with Liver
    Center, Karolinska University Hospital regarding physiological changes in the
    liver during pregnancy as well as fatty liver, NAFLD, chronic liver diseases
    and pregnancy.
    Involved in development and research regarding erythrocyte- and thrombocyte
    immunization during pregnancy together with Division of Clinical Immunology
    and Transfusion medicine, KI and Karolinska University Hospital.

Articles

All other publications

Grants

  • Swedish Research Council
    1 January 2022 - 31 December 2025
    Vacuum assisted delivery (VAD) is associated with significantly higher risk of fetal brain injury and maternal pelvic floor trauma compared to spontaneous vaginal delivery. Today, evidence for safe VAD is limited and accurate methods to evaluate VAD are lacking, which hinders development of safety. The goal of SAFEVAD is to advance biomechanical evidence and develop novel simulation and imaging tools to make VAD safer for both fetus and mother. We will develop a VAD testing platform that combines cutting-edge finite element models and physical phantoms of fetal head and pelvic floor muscles, to provide novel testing settings for VAD safety and performance. The testing platform will be used to i) establish biomechanical evidence for safe VAD, ii) optimize VAD in subject-specific VAD reconstructions, and iii) include novel approaches to guide safe VAD, such as monitoring of when imposed fetal brain deformations are exceeding safe levels, assessed by VAD-integrated miniature quantitative ultrasound. Additionally, ultrasound shear wave elastography (SWE) will be developed to improve assessment of VAD-related pelvic floor muscle injury, and provide accurate pelvic floor muscle mechanical properties for modelling. SAFEVAD is a 4-year project, which integrates multidisciplinary expertise in biomechanical modelling and imaging, obstetrics, fetal and pelvic floor medicine. Our highly related previous research provides a solid basis to initiate this project toward safer VAD.

Employments

  • Affiliated to Research, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2024-2027

Degrees and Education

  • Docent, Karolinska Institutet, 2019
  • Doctor Of Philosophy, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2004
  • University Medical Degree, Karolinska Institutet, 1993

News from KI

Events from KI